SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.

Publication date: Jul 01, 2025

A hallmark of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is the delayed interferon response. Interferons are typically produced upon host recognition of pathogen- or damage-associated molecular patterns, such as nucleic acids. While the mechanisms by which SARS-CoV-2 evades host recognition of its RNA are well studied, how it evades immune responses to cytosolic DNA-leaked from mitochondria or nuclei during infection-remains poorly understood. Here, we demonstrate that the SARS-CoV-2 nucleocapsid protein directly suppresses DNA sensing by cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS). Although primarily known for packaging the viral RNA genome, we uncover that the SARS-CoV-2 nucleocapsid protein also binds DNA with high affinity and competitively blocks cGAS activation. Using cell-free biochemical and biophysical approaches, including single-molecule optical tweezers, we show that the nucleocapsid protein binds to DNA at nanomolar concentrations and cocondenses with DNA at micromolar concentrations, thereby impeding stable cGAS-DNA interactions required for signal propagation. Hyperphosphorylation of the nucleocapsid protein diminishes its competitive binding capacity. Our findings reveal an unexpected role of the SARS-CoV-2 nucleocapsid protein in directly suppressing the cGAS-STING pathway, strongly suggesting that this contributes to the delayed interferon response during infection. This study raises the possibility that nucleocapsid proteins of other RNA viruses may also exhibit moonlighting functions by antagonizing host nucleic acid-sensing pathways.

Open Access PDF

Concepts Keywords
Coronavirus Binding, Competitive
Mitochondria biomolecular condensates
Severe cGAS
Stable cGAS protein, human
Tweezers coronavirus
Coronavirus Nucleocapsid Proteins
Coronavirus Nucleocapsid Proteins
COVID-19
DNA
DNA
Humans
innate immune system
nucleocapsid phosphoprotein, SARS-CoV-2
nucleocapsid protein
Nucleotidyltransferases
Nucleotidyltransferases
Phosphoproteins
Phosphoproteins
Protein Binding
SARS-CoV-2

Semantics

Type Source Name
disease MESH infection
disease IDO host
disease IDO pathogen
disease IDO cell
disease IDO role
disease IDO nucleic acid
drug DRUGBANK Cyclic Guanosine Monophosphate
drug DRUGBANK Adenosine phosphate
disease MESH SARS CoV 2 infection
pathway REACTOME Innate Immune System
disease IDO replication
pathway REACTOME Immune System
pathway KEGG Viral replication
drug DRUGBANK Guanosine
drug DRUGBANK ATP
disease IDO production
disease IDO protein
disease IDO process
drug DRUGBANK Sodium lauryl sulfate
disease IDO site

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *